386 related articles for article (PubMed ID: 29603109)
1. Use of Proton Pump Inhibitors and the Risk of Acute Kidney Injury Among Patients with Rheumatoid Arthritis: Cohort Study.
Svanström H; Lund M; Melbye M; Pasternak B
Drug Saf; 2018 Aug; 41(8):817-826. PubMed ID: 29603109
[TBL] [Abstract][Full Text] [Related]
2. Concomitant use of low-dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis.
Svanström H; Lund M; Melbye M; Pasternak B
Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):885-893. PubMed ID: 29797447
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
Hart E; Dunn TE; Feuerstein S; Jacobs DM
Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
[TBL] [Abstract][Full Text] [Related]
4. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury.
Leonard CE; Freeman CP; Newcomb CW; Reese PP; Herlim M; Bilker WB; Hennessy S; Strom BL
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1155-72. PubMed ID: 22887960
[TBL] [Abstract][Full Text] [Related]
6. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.
Yang Y; George KC; Shang WF; Zeng R; Ge SW; Xu G
Drug Des Devel Ther; 2017; 11():1291-1299. PubMed ID: 28479851
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population-based cohort study.
Munch PV; Nørgaard M; Heide-Jørgensen U; Jensen SK; Birn H; Christiansen CF
Int J Cancer; 2024 Apr; 154(7):1164-1173. PubMed ID: 37983738
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis.
Tergast TL; Wranke A; Laser H; Gerbel S; Manns MP; Cornberg M; Maasoumy B
Liver Int; 2018 Sep; 38(9):1602-1613. PubMed ID: 29675988
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors and acute kidney injury: a nested case-control study.
Klepser DG; Collier DS; Cochran GL
BMC Nephrol; 2013 Jul; 14():150. PubMed ID: 23865955
[TBL] [Abstract][Full Text] [Related]
10. Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.
Raaschou P; Simard JF; Holmqvist M; Askling J;
BMJ; 2013 Apr; 346():f1939. PubMed ID: 23568792
[TBL] [Abstract][Full Text] [Related]
11. The association between proton pump inhibitor use and risk of post-hospitalization acute kidney injury: a multicenter prospective matched cohort study.
Zhang Y; Ghahramani N; Razjouyan H; Ba DM; Chinchilli VM
BMC Nephrol; 2023 May; 24(1):150. PubMed ID: 37237361
[TBL] [Abstract][Full Text] [Related]
12. Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.
Klatte DCF; Gasparini A; Xu H; de Deco P; Trevisan M; Johansson ALV; Wettermark B; Ärnlöv J; Janmaat CJ; Lindholm B; Dekker FW; Coresh J; Grams ME; Carrero JJ
Gastroenterology; 2017 Sep; 153(3):702-710. PubMed ID: 28583827
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects of proton pump inhibitors (PPIs) on the renal system using data mining algorithms (DMAs).
Jain D; Sharma G; Kumar A
Expert Opin Drug Saf; 2023; 22(8):741-752. PubMed ID: 36888736
[TBL] [Abstract][Full Text] [Related]
14. The Association Between Proton Pump Inhibitor Use With Acute Kidney Injury and Chronic Kidney Disease.
Kamal F; Khan MA; Molnar MZ; Howden CW
J Clin Gastroenterol; 2018 Jul; 52(6):468-476. PubMed ID: 29668562
[TBL] [Abstract][Full Text] [Related]
15. Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.
Chen G; Ning LJ; Qin Y; Zhao B; Mei D; Li XM
J Gastroenterol Hepatol; 2021 Jan; 36(1):156-162. PubMed ID: 32542684
[TBL] [Abstract][Full Text] [Related]
16. Proton Pump Inhibitors Are Not Associated With Acute Kidney Injury in Critical Illness.
Lee J; Mark RG; Celi LA; Danziger J
J Clin Pharmacol; 2016 Dec; 56(12):1500-1506. PubMed ID: 27492273
[TBL] [Abstract][Full Text] [Related]
17. Nephrotoxic potential of proton pump inhibitors.
Arif F
Eur J Intern Med; 2017 Jul; 42():e16. PubMed ID: 28377063
[No Abstract] [Full Text] [Related]
18. Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis.
Makunts T; Cohen IV; Awdishu L; Abagyan R
Sci Rep; 2019 Feb; 9(1):2282. PubMed ID: 30783195
[TBL] [Abstract][Full Text] [Related]
19. Regular use of proton pump inhibitor and risk of rheumatoid arthritis in women: a prospective cohort study.
Yuan J; Zhang C; Sparks JA; Malspeis S; Tsoi KK; Kim JH; Fisher BA; Gao F; Sumerlin T; Liu Y; Liu Y; Pan Y; He Y; Sung JJY
Aliment Pharmacol Ther; 2020 Aug; 52(3):449-458. PubMed ID: 32598046
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
